KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Gains from Investment Securities (2016 - 2026)

CRISPR Therapeutics AG (CRSP) has disclosed Gains from Investment Securities for 11 consecutive years, with $86000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 99.43% to $86000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.4 million through Dec 2025, down 26.99% year-over-year, with the annual reading at $1.2 million for FY2025, 83.45% down from the prior year.
  • Gains from Investment Securities hit $86000.0 in Q4 2025 for CRISPR Therapeutics AG, down from $6.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $53.1 million in Q4 2022 to a low of -$6.1 million in Q1 2022.
  • Historically, Gains from Investment Securities has averaged $5.4 million across 5 years, with a median of $1.0 million in 2023.
  • Biggest YoY gain for Gains from Investment Securities was 5419.34% in 2022; the steepest drop was 195.49% in 2022.
  • Year by year, Gains from Investment Securities stood at -$4.7 million in 2021, then soared by 1231.39% to $53.1 million in 2022, then crashed by 91.02% to $4.8 million in 2023, then surged by 217.98% to $15.2 million in 2024, then plummeted by 99.43% to $86000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for CRSP at $86000.0 in Q4 2025, $6.7 million in Q3 2025, and $786504.0 in Q2 2025.